DANIEL J BOOSER to Maximum Tolerated Dose
This is a "connection" page, showing publications DANIEL J BOOSER has written about Maximum Tolerated Dose.
Connection Strength
0.075
-
Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer. Cancer Chemother Pharmacol. 2002 Jul; 50(1):6-8.
Score: 0.041
-
A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer. Cancer. 2012 May 01; 118(9):2378-84.
Score: 0.020
-
Bortezomib (VELCADE) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits. Ann Oncol. 2006 May; 17(5):813-7.
Score: 0.013